| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expense), net | 433 | 742 | 963 | -419 |
| Net income (loss) before income taxes | 21,160 | -11,834 | -25,783 | 5,823 |
| Income tax benefit | -407 | -2,442 | -6,940 | -6,508 |
| Net income (loss) and comprehensive income (loss) | 21,567 | -9,392 | -18,843 | 12,331 |
| Accretion of redeemable convertible preferred stock to redemption value | 140 | 129 | 121 | - |
| Cumulative dividend on redeemable convertible preferred stock | 2,734 | 2,681 | 2,627 | - |
| Undistributed earnings allocated to participating redeemable convertible preferred stock | 4,168 | - | - | - |
| Net income (loss) attributable to common stockholders, basic, total | 14,525 | -12,202 | -21,591 | - |
| Basic | 126,881,709 | 126,853,536 | 126,295,642 | 132,575,301 |
| Earnings per share-basic | 0.11 | -0.1 | -0.17 | 0.09 |
| Earnings per share-diluted | 0.11 | -0.1 | -0.17 | 0.09 |
| Weighted-average common shares outstandingdiluted | 130,848,995 | 126,853,536 | 126,295,642 | 133,926,755 |
Organogenesis Holdings Inc. (ORGO)
Organogenesis Holdings Inc. (ORGO)